Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3

Bristol-Myers Squibb · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
hepatitis c virus (hcv), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 852567
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.